31 May 2012
Medication already commonly used to thwart the effects of diabetes could also enhance traumatic brain injury (TBI) treatment in the years ahead.
New research commissioned by the United States Air Force has studied the benefits that Exendin-4, an FDA-approved diabetes drug, can have on other health problems.
The study, which was led by professor Chaim Pick, from Tel Aviv University's Sackler Faculty of Medicine, revealed that the medication reduces the damage that animal models are subjected to when suffering TBI.
According to the researchers, the Exendin-4 drug is effective as it can provide enhanced protection to neurons when the body suffers from such disorders as Alzheimer's disease.
Professor Pick commented: "We are moving in the right direction. Now we need to find the right dosage and delivery system, then build a cocktail of drugs that will increase the therapeutic value of this concept."
The research comes soon after a YouGov poll found that 63 per cent of people have expressed concern about dementia and hope to learn more about the serious neurological disorder.
Posted by Jeanette Royston
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.